Arwr stock zacks
Zacks Investment Research Zacks Investment Research Page 2 scr.zacks.com WHATS NEW Update on ARO-AAT Phase I Program for Alpha-1 Liver Disease On June 29, 2018, Arrowhead presented preclinical and initial clinical data on ARO-AAT for the ARWR - Arrowhead Pharma News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. ARWR Price Target and Analyst Ratings (Arrowhead ... Nov 09, 2019 · Their average twelve-month price target is $62.13, suggesting that the stock has a possible upside of 137.84%. The high price target for ARWR is $81.00 and the low price target for ARWR is $29.00. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy." Arrowhead Pharmaceuticals, Inc. (ARWR) Dividend Date & ...
Arrowhead Pharmaceuticals Inc's stock rating is based on fundamental analysis. Don't miss ARWR stock next rating changes
Real-time trade and investing ideas on Arrowhead Research Corp. ARWR from the largest community of traders and investors. ARWR Stock Price, Forecast & News (Arrowhead Pharmaceuticals) Exploring Arrowhead Pharmaceuticals (NASDAQ:ARWR) stock? View ARWR's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Forum ... Find the latest Arrowhead Pharmaceuticals, Inc. (ARWR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Arrowhead Pharma Stock Quote: ARWR Stock News, Quotes ...
ARWR Price Target - ETF Channel
Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R Earnings Whisper Number for ARWR: Arrowhead Pharma Aug 05, 2019 · Arrowhead Pharma (ARWR) reports earnings on 5/6/2020. Shares are down 38.9% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.
ARWR - Stock quote for ARROWHEAD PHARMACEUTICALS ... - MSN
11 Dec 2019 Arrowhead Pharmaceuticals (NASDAQ: ARWR), Blueprint Medicines These stocks are too risky to form a cornerstone of anyone's stock 25 Jun 2013 another small cap biotech company Arrowhead Research Corp (NASDAQ: ARWR) which I have no business relationship with any company whose stock is I work as a Consultant Analyst for Zacks Investment Research.
Finance - Zacks
Stock quote for Arrowhead Pharmaceuticals, Inc. Common Stock Common Stock (ARWR) with real-time last sale and extended hours stock prices, …
Oct 18, 2019 · Arrowhead Pharmaceuticals Is Flying Higher on the Charts Before I give my recommendation I want to visit with the charts and indicators. ETFs Holding ARWR | Arrowhead Pharmaceuticals Inc | ETF ... ARWR Description — Arrowhead Pharmaceuticals Inc. Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of RNA chemistries and several modes of delivery, Co.'s therapies trigger the RNA interference (RNAi) mechanism to induce knockdown of target genes. Finance - Zacks The Zacks Personal Finance Channel provides guidance about investing, insurance, retirement planning and taxes so readers can make informed decisions about their financial futures. ARWR -- Is Its Stock Price A Worthy Investment? Learn More. ARWR Stock Summary. ARWR's price/sales ratio is 16.75; that's higher than the P/S ratio of 94.22% of US stocks. Over the past twelve months, ARWR has reported earnings growth of -245.54%, putting it ahead of merely 6.04% of US stocks in our set.